Eli Lilly CEO David Ricks Unveils $6B Alabama Plant to Produce New Obesity Pill
Eli Lilly CEO David Ricks has announced a new $6 billion manufacturing plant in Alabama dedicated to producing the company's next-generation obesity pill. The move signals Lilly's aggressive expansion as global demand for weight-loss drugs soars.